Thank you very much.
Thank you to all the witnesses this afternoon for your very succinct and interesting presentations.
My first question is to Mr. Brooks. You talked about balance and ICR funding, and you had a recommendation for a greater proportion of funding for ICR. We've also been talking about looking at the balance of funding between pure research funding and research that's more product-oriented--more commercialization.
I'd be interested in your views, or the views of anyone else, about the current balance of our investments in pure research versus other kinds of research--perhaps the kind of funding you're looking for, Mr. Watzke, which is very specific and niche-oriented.
Clearly we need to make some change to the balance. What would your recommendations be?